The number of people with susceptibility test result for rifampicin in Uganda
Uganda: The number of people with susceptibility test result for rifampicin was 28,418 in 2021. ▲ Rising
Latest (2021)
28,418
Change on year
up 46.5%
World rank
11th
of 155 countries
All-time high
29,900
in 2019
All-time low
15,644
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Uganda, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Uganda recorded 28,418 for the number of people with susceptibility test result for rifampicin in 2021.
That represents a change of up 46.5% on the previous year and up 81.7% over five years.
Uganda ranks 11th of 155 countries on this measure, in the top 10%.
The number of people with susceptibility test result for rifampicin in Uganda, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 15,644 | — |
| 2018 | 23,566 | +50.6% |
| 2019 | 29,900 | +26.9% |
| 2020 | 19,401 | -35.1% |
| 2021 | 28,418 | +46.5% |
Uganda compared with similar countries
- Uganda's 28,418 is above the median for low income countries, which is 1,934, 14.7× the median. (15 countries reporting)
- Uganda's 28,418 is above the median for Sub-Saharan Africa, which is 2,015, 14.1× the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 23,037 | 15,644 | 29,900 | 3 |
| 2020s | 23,910 | 19,401 | 28,418 | 2 |
Countries ranked near Uganda
More health data for Uganda
- Un projection of annual infant deaths, annual growth rate -2.2 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.34 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 853.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 6,666 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 111 (2025)
- Population ages 00-04, female, annual growth rate 1.28 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0787 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.34 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Uganda?
- The number of people with susceptibility test result for rifampicin in Uganda was 28,418 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Uganda?
- The highest recorded value was 29,900 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Uganda?
- The lowest recorded value was 15,644 in 2017.
- How does Uganda rank for the number of people with susceptibility test result for rifampicin?
- Uganda ranks 11th out of 155 countries with data for 2021.
- Where does this Uganda data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).